Imbalance between protective (adiponectin) and prothrombotic (Plasminogen Activator Inhibitor-1) adipokines in metabolic syndrome

Diabetes and Metabolic Syndrome: Clinical Research and Reviews

Volumn 8, Issue 3, 2014, Pages 152-155

  Ahirwar, Ashok Kumar ^a   Jain, Anju ^a   Goswami, Binita ^a   Bhatnagar, M K ^a   Bhatacharjee, Jayashree ^b  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

^b SAFDARJUNG HOSPITAL   (India)

Author keywords

Adiponectin; Metabolic syndrome; Plasminogen Activator Inhibitor 1

Indexed keywords

ADIPONECTIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; AUTACOID; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; METABOLIC SYNDROME X; OBESITY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST HIP RATIO; BLOOD; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; INSULIN RESISTANCE; INTRAABDOMINAL FAT; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INFLAMMATION MEDIATORS; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 84907716359     PISSN: 18714021     EISSN: 18780334     Source Type: Journal    
DOI: 10.1016/j.dsx.2014.04.035     Document Type: Article

References (34)

1. D.L. Longo, A.S. Fauci, and D.L. Kasper Harrison's principles of internal medicine 18th ed. 2012 McGraw-Hill New York [chapter 242], The Metabolic Syndrome; 1992
2. A. Gupta, R. Gupta, and M. Sarna Prevalence of diabetes, impaired fasting glucose and insulin resistance syndrome in an urban Indian population Diabetes Res Clin Pract 61 2003 69 76
3. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey JAMA 287 2002 356 359
4. B. Balkau, M. Vernay, and L. Mhamdi The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R Study Diabetes Metab 29 2003 526 532
5. A. Ramachandran, C. Snehalatha, and K. Satyavani Metabolic syndrome in urban Asian Indian Adults population study using modified ATP III criteria Diabetes Res Clin Pract 60 2003 199 204
6. D. Eapen, G.L. Kalra, and N. Merchant Metabolic syndrome and cardiovascular disease in South Asians Vasc Health Risk Manag 5 2009 731 743
7. P. Kaur, E. Radhakrishnan, and S.R. Rao The metabolic syndrome and associated risk factors in an urban industrial male population in South India JAPI 58 June 2010 363
8. S. Grazyna Pro-inflammatory and prothrombotic factors and metabolic syndrome eJIFCC 18 1 2007 [cited 19.09.11] Available from: http://www.ifcc.org/index.asp?cat=Publications&scat=eJIFCC-&suba=Vol-18-No-1&subx=Proinflammatory%20and%20prothrombotic%20Factors%20and%20Metabolic%20S ndrome%20&zip=1&dove=1&zona=full&numero=&aq=1
9. L. Duvnjak, and M. Duvnjak The metabolic syndrome - an ongoing story J Physiol Pharmacol 60 7 2009 19 24
10. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance Science 259 1993 87 91
11. I. Shimomura, T. Funahashi, and M. Takahashi Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity Nat Med 2 1996 800 803
12. C.M. Steppan, S.T. Bailey, and S. Bhat The hormone resistin links obesity to diabetes Nature 409 2001 307 312
13. P. Vague, V. Juhan, and M.F. Aillaud Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level and relative body weight in normal and obese subjects Metabolism 35 1986 250 253
14. V. Juhan, M.C. Alessi, and P. Vague Increased plasma plasminogen activator 1 level. A possible link between insulin resistance and atherothrombosis Diabetologia 34 1991 457 462
15. W. Dichtl, L. Nilsson, and I. Goncalves Very low-density lipoprotein activates nuclear factor-kB in endothelial cells Circ Res 84 1999 1085 1094
16. M.K. Garg, M.K. Dutta, and N. Mahalle Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome Ind J Endocrinol Metab 16 January-February (1) 2012 116 123
17. J.B. Marsh Lipoprotein metabolism in obesity and diabetes: insights from stable isotope kinetic studies in humans Nutr Rev 61 2003 363 375
18. M. Neumeier, A. Sigruener, and E. Eggenhofer High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes Biochem Biophys Res Commun 352 2 2007 543 548
19. G.M. Reaven Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
20. G.M. Reaven Pathophysiology of insulin resistance in human disease Physiol Rev 75 1995 473 486
21. Y. Hattori, K. Akimoto, and S.S. Gross Angiotensin-II-induced oxidative stress elicits hypoadiponectinaemia in rats Diabetologia 48 6 2005 1066 1074
22. S.R. Mahadik, S.S. Deo, and S.D. Mehtalia Association of adiposity, inflammation and atherosclerosis: the role of adipocytokines and CRP in Asian Indian subjects Metab Syndr Relat Disord 6 2008 121 128
23. V. Mohan, R. Deepa, and R. Pradeepa Association of low adiponectin levels with the metabolic syndrome - The Chennai Urban Rural Epidemiology Study (CURES-4) Metabolism 54 2005 476 481
24. W.S. Yang, W.J. Lee, and T. Funahashi Plasma adiponectin levels in overweight and obese Asians Obes Res 10 2002 1104 1110
25. Y. Seino, H. Hirose, and I. Saito High molecular weight multimer form of adiponectin as a useful marker to evaluate insulin resistance and metabolic syndrome in Japanese men Metabolism 56 2007 1493 1499
26. J. Hung, B.M. McQuillan, and P.L. Thompson Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity Int J Obes (Lond) 32 2008 772 779
27. D.A. Tanianski, E.M. Firova, and L.V. Shatilina Adiponectin lowering in metabolic syndrome and independent relation to hypertriglyceridemia Kardiologiia 48 2008 20 25
28. H.K. Ryu, S.Y. Yu, and J.S. Park Hypoadiponectinemia is strongly associated with metabolic syndrome in Korean type 2 diabetes patients J Am Coll Nutr 29 2010 171 178
29. P.E. Scherer Adipose tissue: from lipid storage compartment to endocrine organ Diabetes 55 2006 1537 1545
30. P. Vague, I. Juhan-Vague, and M.F. Aillaud Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects Metabolism 35 1986 250 253
31. F. Samad, K. Yamamoto, and D.J. Loskutoff Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide J Clin Invest 97 1996 37 46
32. I. Mertens, A. Verrijken, and J.J. Michiels Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome Int J Obes (Lond) 30 2006 1308 1314
33. Y.Y. Chou, W.H. Sheu, and Y.J. Tang Plasminogen activator inhibitor type 1 (PAI-1) is a valuable biomarker for predicting the metabolic syndrome (MS) in institutionalized elderly residents in Taiwan Arch Gerontol Geriatr 49 Suppl. 2 2009 41 45
34. I. Juhan-Vague, M.C. Alessi, and A. Mavri Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk J Thromb Haemost 1 2003 1575 1579